美國NuGEN Technologies Inc
NuGEN公司成功革新了擴增和樣品制備技術,使生命科學研究者能將那些極小的、易降解的和難以取代的標本發掘成為基因研究樣本。
NuGEN公司的微量核酸制備技術為世界頂尖的醫藥公司、科研院所和尖端的生物技術公司帶來了解決方案,以滿足他們在臨床研究、表達譜分析、生物標志物及標簽的發現過程中遇到的艱難挑戰。
NuGEN為各種尖端的基因分析平臺提供了簡捷、可靠、自動化的工作流程,包括新一代測序、微陣列分析和定量PCR。產品用于樣品的制備,包括純化RNA、DNA或者細胞裂解液,為特異的下游分析做準備。
NuGEN公司的產品主要分兩部分:
Next-Generation Sequencing(NGS),Microarrays and qPCR。
NuGEN develops and commercializes rapid, high-sensitivity, and high-throughput amplification and labeling systems for genomic analysis.
Our innovations have captured the attention and imagination of life scientists studying the molecular basis of cellular responses, elucidating disease pathways, investigating novel expression biomarkers, discovering disease signatures, identifying and validating drug targets, and more.
Using our proprietary technologies as the foundation of products, NuGEN develops and commercializes solutions for high-sensitivity nucleic acid amplification and target preparation. With these solutions, life scientists can generate more meaningful answers, increase productivity, and achieve more significant discoveries in their quest to understand the molecular basis of disease, to discover novel biomarkers, and to identify and validate new drug targets.
NuGEN uniquely enables researchers to perform robust, high-fidelity expression analysis from limited and highly compromised clinical specimens. These solutions help researchers unlock discoveries in previously inaccessible samples such as formalin-fixed paraffin-embedded (FFPE), laser-captured, micro-dissected tissue (LCM), and others.
Founded in 2000, NuGEN Technologies, Inc. is privately held and headquartered in San Carlos, California near the heart of Silicon Valley. The company has commercialized numerous proprietary RNA amplification and labeling technologies and products for discovery and clinical research applications.